Our latest Investing Matters Podcast episode with QuotedData's Edward Marten has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE
Stefan Bernstein explains how the EU/Greenland critical raw materials partnership benefits GreenRoc
Stefan Bernstein explains how the EU/Greenland critical raw materials partnership benefits GreenRocView Video
Utilico Insights - Jacqueline Broers assesses why Vietnam could be the darling of Asia for investors
Utilico Insights - Jacqueline Broers assesses why Vietnam could be the darling of Asia for investorsView Video

Latest Share Chat

UPDATE: Booster Covid jab to be offered in UK to people aged over 50

Tue, 14th Sep 2021 11:47

(Alliance News) - Booster vaccines will be offered to people aged 50 and over, those in care homes and frontline health and social care workers, the UK government has announced.

Experts said the Pfizer/BioNTech vaccine should be used as the booster dose for more than 30 million people, and that it was safe to be given alongside the usual winter flu jab.

All those who are clinically extremely vulnerable and anyone aged 16 to 65 in an at-risk group group for Covid (who were in priority groups one to nine during the initial vaccine rollout) will also be eligible for a jab.

Three vaccines have been approved as safe and effective as boosters – AstraZeneca PLC, Pfizer Inc and Moderna Inc – but experts have decided to opt for Pfizer as a preference after studies showed it is well tolerated and works well as a booster.

The Pfizer jab as a booster can be given to people who had two doses of AstraZeneca previously.

If necessary, Moderna may be used as an alternative, but as a half-dose booster shot after studies showed it was effective with few side-effects.

People should receive their third booster dose at least six months after they received their second dose of a Covid vaccine.

When there is more data, experts plan to look at whether boosters should also be offered to healthy people under the age of 50.

By Jane Kirby, Ella Pickover and David Hughes

source: PA

Copyright 2021 Alliance News Limited. All Rights Reserved.

Related Shares

More News
27 Mar 2024 12:02

LONDON MARKET MIDDAY: FTSE 100 underperforms ahead of US PCE data

(Alliance News) - Stock prices in London were lower at midday on Wednesday, but trade was more confident in mainland Europe, with focus turning to the...

27 Mar 2024 11:56

C4X Discovery seeks AIM delisting but half-year revenue skyrockets

(Alliance News) - C4X Discovery Holdings PLC shares plunged on Wednesday after it said it plans to delist from AIM in London, due to "the recent downt...

27 Mar 2024 09:19

AstraZeneca treatments become "first and only" to be approved in Japan

(Alliance News) - AstraZeneca PLC announced on Wednesday the approval of two of its treatments for use in Japan.

27 Mar 2024 09:03

LONDON MARKET OPEN: FTSE 100 slips as unease lingers before US data

(Alliance News) - Stock prices in London edged lower after the open on Wednesday, with some nervy trade ahead of a US inflation reading later in the w...

27 Mar 2024 08:02

LONDON BRIEFING: Diploma makes buy; Astra wins Japan drug approvals

(Alliance News) - Stocks in London opened in a muted fashion on Wednesday, with some unease lingering in equity markets ahead of a US inflation readin...

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.